Stool transplant from a selected donor for irritable bowel syndrome
Tests donor stool transplants in adults with irritable bowel syndrome and high protein breakdown.
Key facts
- Who runs it
- Madhusudan (Madhu) Grover, MBBS
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Fecal Microbiota Transplantation for IBS
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 43 people, planned
- Started
- 15 Apr 2024
- Expected to end
- 26 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Donor Fecal Microbiota Transplantation
- Autologous Fecal Microbiota Transplantation
- Record updated
- 8 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with irritable bowel syndrome (IBS) with moderate to severe symptoms, not the constipation type. They will get a stool transplant from a donor or from their own stool.
- Age
- 18 Years to 70 Years
- Sex
- Women only
- Disease stage
- IBS by Rome IV criteria, not the constipation-predominant type (non IBS-C). Moderate to severe symptoms, IBS-SSS score of 175 or more.
- Earlier treatment
- No new probiotics, antibiotics or NSAIDs within 4 wks before the study. No treatments that affect bowel movement, except loperamide. No immunosuppressive medicines.
Main reasons for not taking part
- Weak immune system, active cancer, or chronic kidney or liver disease
- Pregnant or breastfeeding
- Other bowel diseases such as IBD, celiac disease or microscopic colitis
- Severe psychiatric disorder (HADS-A or D>16), or alcohol or drug abuse disorder
- Past abdominal surgery, apart from the listed exceptions, or a bleeding disorder
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- IBS defined by Rome IV criteria
- Non IBS-C
- Moderate to severe symptoms defined by IBS-SSS≥175
- Able to safely undergo and consent to colonoscopy
Who cannot take part
- Immune deficiency or treatment with immunosuppressive medications
- Abdominal surgery (exception of splenectomy, partial hepatectomy, partial/unilateral nephrectomy, laparoscopy, pelvic floor repair, mesh, liposuction, fundoplication, tubal ligation, gastric sleeve, oophorectomy, hernia, appendectomy, cholecystectomy, caesarean section and hysterectomy)
- New probiotics or treatment with antibiotics, NSAIDs (within 4 wks prior to study entry)
- Severe bowel or medical disease precluding administration of bowel prep
- Severe bowel or medical disease precluding colonoscopy with conscious sedation
- Active cancer
- Severe psychiatric disorder (HADS-A or D>16), or diagnosed alcohol or drug abuse disorder
- Diagnosed h/o bleeding disorder
- Organic GI diseases (IBD, celiac disease, microscopic colitis)
- Chronic kidney or liver disease
- Absolute neutrophil count (ANC) <500 IU/ml
- Pregnant or lactating
- Use of treatments known to affect colonic motility (with exception of loperamide)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Where in United States
- Mayo Clinic in MinnesotaRochester, United StatesContact: Jonah Pedelty, MSTaking people
About the trial
What the trial wants to find out
The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids.
The 2 groups in the trial
- Donor Fecal Microbiota Transplantation GroupTreatment being tested
Subjects will receive a fecal microbiota transplantation (FMT) using stool from a donor
Treatment: Donor Fecal Microbiota Transplantation
- Autologous Fecal Microbiota Transplantation GroupPlacebo, for comparison
Subjects will receive a fecal microbiota transplantation (FMT) using their own stool
Treatment: Autologous Fecal Microbiota Transplantation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)
- Plain-language title
- Stool transplant from a selected donor for irritable bowel syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05776914, who can take part
- Record updated
- 8 May 2026